- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Hong Kong Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
92
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
92 companies
HBM Holdings
Market Cap: HK$11.8b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$14.06
7D
-9.1%
1Y
1,052.5%
Genor Biopharma Holdings
Market Cap: HK$2.1b
A biopharmaceutical company, focuses on developing and commercializing oncology and autoimmune drugs in China and internationally.
6998
HK$3.94
7D
-5.5%
1Y
n/a
Ocumension Therapeutics
Market Cap: HK$6.8b
Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.
1477
HK$8.30
7D
-6.6%
1Y
55.7%
CARsgen Therapeutics Holdings
Market Cap: HK$10.7b
An investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies, solid tumors, and autoimmune diseases in China.
2171
HK$19.36
7D
-6.7%
1Y
427.5%
Consun Pharmaceutical Group
Market Cap: HK$13.5b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$15.90
7D
-2.1%
1Y
144.6%
China Traditional Chinese Medicine Holdings
Market Cap: HK$12.0b
China Traditional Chinese Medicine Holdings Co.
570
HK$2.38
7D
8.7%
1Y
-45.0%
Zhaoke Ophthalmology
Market Cap: HK$2.0b
An ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People’s Republic of China, South Korea, Hong Kong, and internationally.
6622
HK$3.65
7D
-3.9%
1Y
166.4%
JBM (Healthcare)
Market Cap: HK$2.4b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.96
7D
-2.3%
1Y
211.6%
Sino Biopharmaceutical
Market Cap: HK$143.3b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$8.01
7D
-4.5%
1Y
125.0%
3SBio
Market Cap: HK$73.5b
An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.
1530
HK$30.72
7D
-1.7%
1Y
403.6%
Brii Biosciences
Market Cap: HK$1.4b
Focuses on developing therapies for the treatment of infectious and central nervous system diseases in China and the United States.
2137
HK$1.93
7D
-7.2%
1Y
77.1%
VISEN Pharmaceuticals
Market Cap: HK$4.4b
An investment holding company, engages in the development and commercialization of paradigm-shifting endocrine therapies in the Chinese Mainland.
2561
HK$41.66
7D
-6.3%
1Y
n/a
Shandong Xinhua Pharmaceutical
Market Cap: HK$10.1b
Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.
719
HK$7.21
7D
-4.2%
1Y
30.6%
Modern Chinese Medicine Group
Market Cap: HK$525.6m
An investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China.
1643
HK$0.73
7D
-1.4%
1Y
124.6%
TransThera Sciences (Nanjing)
Market Cap: HK$63.4b
TransThera Sciences (Nanjing), Inc., clinical stage biopharmaceutical company, discovers, develops, and commercializes small molecule therapies for oncology, inflammatory, and cardiometabolic diseases.
2617
HK$159.80
7D
-12.8%
1Y
n/a
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$7.4b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$8.88
7D
-2.7%
1Y
9.6%
Essex Bio-Technology
Market Cap: HK$2.9b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$5.13
7D
-4.5%
1Y
120.2%
Antengene
Market Cap: HK$4.2b
A clinical-stage APAC biopharmaceutical company, develops novel oncology therapies in Greater China and internationally.
6996
HK$6.16
7D
-6.7%
1Y
944.1%
Ascletis Pharma
Market Cap: HK$11.4b
A biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China.
1672
HK$11.51
7D
9.6%
1Y
965.7%
WuXi Biologics (Cayman)
Market Cap: HK$162.6b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269
HK$40.00
7D
2.8%
1Y
188.6%
Abbisko Cayman
Market Cap: HK$11.6b
Engages in the research and development of pharmaceutical products in the People’s Republic of China and the European Union.
2256
HK$17.23
7D
-1.5%
1Y
409.8%
Kontafarma China Holdings
Market Cap: HK$190.0m
An investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediate in Mainland China, Singapore, Taiwan, and internationally.
1312
HK$0.034
7D
-2.9%
1Y
6.3%
Zhongzhi Pharmaceutical Holdings
Market Cap: HK$578.6m
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China.
3737
HK$0.67
7D
-6.9%
1Y
-34.3%
China Shineway Pharmaceutical Group
Market Cap: HK$6.1b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$8.14
7D
-3.6%
1Y
-5.0%
China Health Group
Market Cap: HK$184.1m
An investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China.
8225
HK$0.18
7D
17.1%
1Y
68.2%
Zhejiang Taimei Medical Technology
Market Cap: HK$2.4b
Zhejiang Taimei Medical Technology Co., Ltd.
2576
HK$4.33
7D
-0.9%
1Y
n/a
United Laboratories International Holdings
Market Cap: HK$29.3b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$14.84
7D
-6.1%
1Y
58.4%
Simcere Pharmaceutical Group
Market Cap: HK$33.1b
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.
2096
HK$12.76
7D
-2.3%
1Y
101.3%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.8b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.22
7D
0.8%
1Y
8.0%
Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd
Market Cap: HK$8.2b
Engages in the research, development, manufacture, and sale of bio-pharmaceutical products in the People's Republic of China.
1349
HK$3.54
7D
-7.3%
1Y
80.6%
Grand Pharmaceutical Group
Market Cap: HK$29.4b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$8.40
7D
-4.2%
1Y
79.1%
China Medical System Holdings
Market Cap: HK$34.9b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$14.44
7D
-3.9%
1Y
77.6%
Pak Fah Yeow International
Market Cap: HK$769.8m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.47
7D
-0.4%
1Y
-4.3%
Jacobson Pharma
Market Cap: HK$3.0b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.48
7D
1.4%
1Y
142.6%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$118.5b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$508.00
7D
-0.4%
1Y
200.1%
Lee's Pharmaceutical Holdings
Market Cap: HK$1.4b
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally.
950
HK$2.30
7D
-8.4%
1Y
93.3%